State farmer posts record results
State farmer Pamu has delivered its strongest operating result on record.
Asparagopsis Technologies Limited (ASTEC) is supplying research-grade asparagopsis armata for animal methane mitigation studies, ensuring continued access to one of the world's largest land-based cultivation facilities dedicated to this emerging field of research.
Following CH4 Global's decision to focus on its Australian operations, former leaders from the business partnered with Ocean Beach Aquaculture Park to retain the specialised infrastructure and cultivation expertise developed in Bluff.
The new company will supply high-quality asparagopsis biomass to research institutions undertaking controlled and commercial-scale methane reduction trials internationally.
ASTEC executive director Nigel Little says the company supplies asparagopsis biomass to Australia, USA, Japan and Europe - especially Scandinavia, Netherlands and Ireland for research.
"These are the countries where a number of universities and research institutes have already been studying asparagopsis and where we believe there is demand for larger scale follow-on trials," Little told Rural News.
Asaparagopsis-based feed additives are being offered for sale in Australia and Europe today where they are already approved for sale as a natural feed supplement.
CH4 Global is the leading commercial supplier with their Methane Tamer product, which is formulated with 100% asparagopsis.
However, in New Zealand, all methane inhibitors regardless of type - from natural plants being used as herbal medicines like asparagopsis - through to synthetic chemicals, like novel ingredients, have been arbitrarily classified as Vet Medicines under the NZ legislation.
Little says only one product (using a synthetic chemical) has been submitted for approval to date, and no products have yet been approved.
He believes asparagopsis would be an excellent solution as a natural, safe and affordable inhibitor for high value dairy applications in New Zealand, such as organics, A2 and infant formula. It could be easily added - less than 50 grams per milking - to existing feed supplements given while milking.
“But a lot more investment will be required to prove the exact benefits of asparagopsis in NZ’s farming systems and to collect the data necessary to make a Vet Medicine application, and there doesn’t seem to be any interest in the research sector in NZ to do this work.”
Interest in asparagopsis continues to grow as research demonstrates its potential to significantly reduce enteric methane emissions in ruminants.
However, access to consistent, research-grade material has remained a constraint for many institutions, with much of the global supply directed into proprietary commercial programmes. ASTEC has been established to address this gap by providing researchers with reliable access to high-quality cultivated biomass for independent trials across diverse production systems, cattle breeds and feeding regimes.
The Ocean Beach Aquaculture Park is among the world’s largest land-based asparagopsis cultivation facilities, with existing production capacity of approximately 20,000 daily doses per month and significant scope for future expansion as international research demand grows. The facility leverages naturally cold Southern Ocean water and purpose-built bioreactor infrastructure, drawing on cultivation expertise developed over several years.
FutureFeed holds and licenses global IP for the use of asparagopsis seaweed as a livestock feed ingredient, shown to lower ruminant methane emissions by 80% or more.
FutureFeed chief executive Alex Baker says methane from cattle and sheep dominates New Zealand’s carbon footprint.
“The rising sustainability expectations and competition in global export markets mean this has to change. Accelerating seaweed supply is critical to bring about change, and we are excited to see Asparagopsis Technologies’ actions towards that goal.”
